BRPI0813094A2 - Derivados de 1,2,3,4-tetra-hidro pirrolo (1,2-a) pirazina-6-carboxamidas e de 2,3,4,5-tetra hidro pirrolo (1,2-a) (1,4)-diazepina-7-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica. - Google Patents
Derivados de 1,2,3,4-tetra-hidro pirrolo (1,2-a) pirazina-6-carboxamidas e de 2,3,4,5-tetra hidro pirrolo (1,2-a) (1,4)-diazepina-7-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica.Info
- Publication number
- BRPI0813094A2 BRPI0813094A2 BRPI0813094-9A2A BRPI0813094A BRPI0813094A2 BR PI0813094 A2 BRPI0813094 A2 BR PI0813094A2 BR PI0813094 A BRPI0813094 A BR PI0813094A BR PI0813094 A2 BRPI0813094 A2 BR PI0813094A2
- Authority
- BR
- Brazil
- Prior art keywords
- carboxamides
- pyrorolo
- hydro
- tetra
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0705498A FR2919289B1 (fr) | 2007-07-27 | 2007-07-27 | Derives de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]- diazepine-7-carboxamides, leur preparation et leur application en therapeutique. |
FR0705497A FR2919288B1 (fr) | 2007-07-27 | 2007-07-27 | Derives de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6- carboxamides, leur preparation et leur application en therapeutique. |
PCT/FR2008/001096 WO2009044007A2 (fr) | 2007-07-27 | 2008-07-24 | Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0813094A2 true BRPI0813094A2 (pt) | 2014-12-23 |
Family
ID=40526763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0813094-9A2A BRPI0813094A2 (pt) | 2007-07-27 | 2008-07-24 | Derivados de 1,2,3,4-tetra-hidro pirrolo (1,2-a) pirazina-6-carboxamidas e de 2,3,4,5-tetra hidro pirrolo (1,2-a) (1,4)-diazepina-7-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica. |
Country Status (23)
Country | Link |
---|---|
US (1) | US20100197668A1 (pt) |
EP (1) | EP2185561B1 (pt) |
JP (1) | JP2010534639A (pt) |
KR (1) | KR20100050485A (pt) |
CN (1) | CN101765601A (pt) |
AT (1) | ATE512968T1 (pt) |
AU (1) | AU2008306835A1 (pt) |
BR (1) | BRPI0813094A2 (pt) |
CA (1) | CA2694288A1 (pt) |
CO (1) | CO6290689A2 (pt) |
CY (1) | CY1112121T1 (pt) |
DK (1) | DK2185561T3 (pt) |
EA (1) | EA201070195A1 (pt) |
HR (1) | HRP20110650T1 (pt) |
MA (1) | MA31630B1 (pt) |
MX (1) | MX2010001076A (pt) |
NZ (1) | NZ582871A (pt) |
PL (1) | PL2185561T3 (pt) |
PT (1) | PT2185561E (pt) |
RS (1) | RS51912B (pt) |
SI (1) | SI2185561T1 (pt) |
WO (1) | WO2009044007A2 (pt) |
ZA (1) | ZA201000581B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2919285B1 (fr) * | 2007-07-27 | 2012-08-31 | Sanofi Aventis | Derives de 1-oxo-isoindoline-4-carboxamides et de 1-oxo- 1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur preparation et leur application en therapeutique. |
FR2960876B1 (fr) | 2010-06-03 | 2012-07-27 | Sanofi Aventis | Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique. |
US8822527B2 (en) | 2011-10-17 | 2014-09-02 | Biotheryx, Inc. | Substituted biaryl alkyl amides |
US9284333B2 (en) | 2012-02-03 | 2016-03-15 | Sanofi | Fused pyrroledicarboxamides and their use as pharmaceuticals |
US10431748B2 (en) | 2014-10-30 | 2019-10-01 | Lg Chem, Ltd. | Cyclic compound and organic light-emitting element comprising same |
US10301306B2 (en) | 2014-12-15 | 2019-05-28 | Bristol-Myers Squibb Company | Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors |
CN114522668B (zh) * | 2022-01-13 | 2023-10-13 | 浙江大学杭州国际科创中心 | 乙氧基柱[6]芳烃晶体材料在选择性吸附四氢吡咯中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2003070730A1 (ja) * | 2002-02-22 | 2005-06-09 | 帝人株式会社 | ピロロピリミジン誘導体 |
GB0309221D0 (en) * | 2003-04-23 | 2003-06-04 | Glaxo Group Ltd | Novel compounds |
GB0328900D0 (en) * | 2003-12-12 | 2004-01-14 | Glaxo Group Ltd | Novel compounds |
GB0506562D0 (en) * | 2005-03-31 | 2005-05-04 | Glaxo Group Ltd | Novel compounds |
-
2008
- 2008-07-24 BR BRPI0813094-9A2A patent/BRPI0813094A2/pt not_active IP Right Cessation
- 2008-07-24 WO PCT/FR2008/001096 patent/WO2009044007A2/fr active Application Filing
- 2008-07-24 PL PL08836692T patent/PL2185561T3/pl unknown
- 2008-07-24 NZ NZ582871A patent/NZ582871A/en not_active IP Right Cessation
- 2008-07-24 SI SI200830365T patent/SI2185561T1/sl unknown
- 2008-07-24 PT PT08836692T patent/PT2185561E/pt unknown
- 2008-07-24 EP EP08836692A patent/EP2185561B1/fr active Active
- 2008-07-24 RS RS20110374A patent/RS51912B/en unknown
- 2008-07-24 MX MX2010001076A patent/MX2010001076A/es active IP Right Grant
- 2008-07-24 CA CA2694288A patent/CA2694288A1/fr not_active Abandoned
- 2008-07-24 JP JP2010517449A patent/JP2010534639A/ja not_active Withdrawn
- 2008-07-24 DK DK08836692.7T patent/DK2185561T3/da active
- 2008-07-24 CN CN200880100661.4A patent/CN101765601A/zh active Pending
- 2008-07-24 AT AT08836692T patent/ATE512968T1/de active
- 2008-07-24 KR KR1020107001731A patent/KR20100050485A/ko not_active Application Discontinuation
- 2008-07-24 EA EA201070195A patent/EA201070195A1/ru unknown
- 2008-07-24 AU AU2008306835A patent/AU2008306835A1/en not_active Abandoned
-
2010
- 2010-01-26 CO CO10007695A patent/CO6290689A2/es not_active Application Discontinuation
- 2010-01-26 US US12/693,601 patent/US20100197668A1/en not_active Abandoned
- 2010-01-26 ZA ZA2010/00581A patent/ZA201000581B/en unknown
- 2010-02-24 MA MA32647A patent/MA31630B1/fr unknown
-
2011
- 2011-09-09 HR HR20110650T patent/HRP20110650T1/hr unknown
- 2011-09-15 CY CY20111100888T patent/CY1112121T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1112121T1 (el) | 2015-11-04 |
WO2009044007A3 (fr) | 2009-09-17 |
DK2185561T3 (da) | 2011-10-10 |
EP2185561A2 (fr) | 2010-05-19 |
EP2185561B1 (fr) | 2011-06-15 |
AU2008306835A1 (en) | 2009-04-09 |
ZA201000581B (en) | 2011-04-28 |
NZ582871A (en) | 2011-09-30 |
KR20100050485A (ko) | 2010-05-13 |
EA201070195A1 (ru) | 2010-10-29 |
PL2185561T3 (pl) | 2011-11-30 |
MX2010001076A (es) | 2010-03-09 |
PT2185561E (pt) | 2011-09-07 |
CA2694288A1 (fr) | 2009-04-09 |
MA31630B1 (fr) | 2010-08-02 |
JP2010534639A (ja) | 2010-11-11 |
WO2009044007A2 (fr) | 2009-04-09 |
HRP20110650T1 (hr) | 2011-10-31 |
CO6290689A2 (es) | 2011-06-20 |
SI2185561T1 (sl) | 2011-10-28 |
US20100197668A1 (en) | 2010-08-05 |
RS51912B (en) | 2012-02-29 |
CN101765601A (zh) | 2010-06-30 |
ATE512968T1 (de) | 2011-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI200800207A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina | |
NI201000005A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico. | |
HN2009000784A (es) | Dihidropirazolonas sustituidas | |
BRPI0810412A2 (pt) | Derivados de triazolo piridina-carboxamidas e triazolo pirimidina - carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica | |
MY153921A (en) | Aminopyrazole derivatives | |
BRPI0813094A2 (pt) | Derivados de 1,2,3,4-tetra-hidro pirrolo (1,2-a) pirazina-6-carboxamidas e de 2,3,4,5-tetra hidro pirrolo (1,2-a) (1,4)-diazepina-7-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica. | |
BRPI0923875A2 (pt) | Derivados de 2-piridin-2-il-pirazol-3 (2h)-ona, o respectivo preparo e a respectiva aplicação terapêutica. | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
CR20110701A (es) | Derivados de pirazoles, su preparacion y su aplicacion terapeutica. | |
BRPI0923182A2 (pt) | derivados de 6-cicloamino-2,3-di-piridinil-imidazo[1,2-b]piridazina, o respectivo preparo e a respectivo preparo e a respectiva aplicação terapêutica | |
EA200801678A1 (ru) | Применение производных триазина для производства лекарственного средства, обладающего заживляющим или ангиогенным эффектом | |
BRPI0822054A2 (pt) | Derivados de azetidinas, o respectivo preparo e a respectiva aplicação em terapêutica | |
BRPI0821426A2 (pt) | Compostos de n-fenil-imidazol[1,2-a]piridina-2-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica. | |
BRPI0806969A2 (pt) | Derivados de azabicicloalcano, o respectivo preparo e a respectiva aplicação em terapêutica | |
BRPI0821674A2 (pt) | Derivados de n-fenil-imidazo[1,2-a] piridina-2- carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica | |
BRPI0812588A2 (pt) | Derivados de 1-benzilpirazol, o respectivo preparo e a respectiva aplicação em terapêutica | |
WO2007121883A3 (de) | 1,4:3,6-dianhydromannitol-derivate und deren verwendung | |
UY30235A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
BRPI0813624A2 (pt) | derivados de 1-oxo-isoindolina-4-carboxamidas e de 1-oxo-1,2,3,4-tetra-hidroisoquinoleína-5-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica. | |
BRPI0821823A2 (pt) | Derivados de n-heterocíclico-6-heterocíclico-imidazo[1,2-a]piridin a-2-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica | |
UY30236A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
DOP2007000060A (es) | Inhibidores de la adenilato ciclasa soluble | |
EP1968383A4 (en) | Heterocycles and their derivatives, method of preparation and their use in therapy | |
UY29583A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
BRPI1008544A2 (pt) | derivados de n-[(6-aza-biciclo [3.2.1] oct-1-il)-aril-metil]-benzamida, o respectivo preparo e a respectiva aplicação em terapêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |